Literature DB >> 7634904

Mediastinal malignant epithelioid schwannoma.

I Fukai1, A Masaoka, Y Yamakawa, H Niwa, T Eimoto.   

Abstract

A case of mediastinal malignant epithelioid schwannoma (MES) is reported. The tumor probably arose in the vagal nerve, and the trachea was involved. A few months after excision of the primary tumor, multiple metastases appeared in lung, cervical spine, and neck lymph nodes. Microscopically, the tumor showed a highly cellular area resembling melanoma or carcinoma. Immunolabeling was done for S-100 protein, keratin, and melanoma-associated antigen. Examination of the entire lesion and in situ characteristics of the tumor involving the vagal nerve were helpful in making the correct diagnosis. Mediastinal MES, to our knowledge, has not been reported to date in the English-language medical literature.

Entities:  

Mesh:

Year:  1995        PMID: 7634904     DOI: 10.1378/chest.108.2.574

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  4 in total

1.  Primary Malignant Peripheral Nerve Sheath Tumor of the Trachea: a Case Report with Brief Review of Literature.

Authors:  Hemantkumar Nemade; Syed Nusrath; Jayakarthik Y; G T Jonathan; L M Chandra Sekhara Rao S; Daphne Fonseca; T Subramanyeshwar Rao
Journal:  Indian J Surg Oncol       Date:  2019-03-22

2.  Cervico-mediastinal schwannoma of the vagus nerve: resection with intraoperative nerve monitoring.

Authors:  Andrea Imperatori; Gianlorenzo Dionigi; Lavinia De Monte; Valentina Conti; Nicola Rotolo
Journal:  Updates Surg       Date:  2011-01-06

3.  Long-term survival after removal of a malignant peripheral nerve sheath tumor originating in the anterior mediastinum.

Authors:  Takehiko Shimoyama; Katsuo Yoshiya; Yasushi Yamato; Teruaki Koike; Keiichi Honma
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-06-17

4.  Malignant schwannoma of the upper mediastinum originating from the vagus nerve.

Authors:  Fumihiro Shoji; Riichiroh Maruyama; Tatsuro Okamoto; Hiroshi Wataya; Kenichi Nishiyama; Yukito Ichinose
Journal:  World J Surg Oncol       Date:  2005-10-06       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.